The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
KEYNOTE-045: Randomized phase 3 trial of pembrolizumab (MK-3475) versus paclitaxel, docetaxel, or vinflunine for previously treated metastatic urothelial cancer.
 
Joaquim Bellmunt
Consulting or Advisory Role - Astellas Pharma; Pfizer; Pierre Fabre
Research Funding - Millennium (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - MSD Oncology; Pfizer
 
Guru Sonpavde
Consulting or Advisory Role - Bayer; Genentech; GlaxoSmithKline; Merck; Sanofi
Research Funding - Onyx (Inst)
 
Ronald De Wit
Honoraria - Merck; Sanofi
Consulting or Advisory Role - Lilly; Roche Pharma AG; Sanofi
Research Funding - Millennium; Sanofi
 
Toni K. Choueiri
Honoraria - NCCN; UpToDate
Consulting or Advisory Role - AVEO; Bayer; GlaxoSmithKline; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Exelixis (Inst); GlaxoSmithKline (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); TRACON Pharma (Inst)
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; GlaxoSmithKline; Novartis; Pfizer
 
Arlene O. Siefker-Radtke
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Janssen; Merck; NCCN; Threshold Pharmaceuticals
Research Funding - Dendreon; Genentech; Michael and Sherry Sutton Fund for Urothelial Cancer; Millennium; NIH
Patents, Royalties, Other Intellectual Property - Methods of characterizing and treating molecular subsets of muscle-invasive bladder cancer.
 
Elizabeth R. Plimack
Consulting or Advisory Role - Astellas Pharma; Dendreon; Genentech; GlaxoSmithKline; Merck; Novartis
Research Funding - Acceleron Pharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Dendreon (Inst); GlaxoSmithKline (Inst); Lilly (Inst); Merck (Inst); Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - Patent Pending (Inst)
 
Nicole M. Lewis
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Holly Brown
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Yabing Mai
Employment - Merck; Merck (I)
Stock and Other Ownership Interests - Merck
 
Christine K. Gause
Employment - Merck
Stock and Other Ownership Interests - Merck
 
David Ross Kaufman
Employment - Merck
Stock and Other Ownership Interests - Merck
Research Funding - Merck
Patents, Royalties, Other Intellectual Property - Merck
Travel, Accommodations, Expenses - Merck
 
Dean F. Bajorin
No Relationships to Disclose